Hong Li
Emory University
Dr. Li is a clinical geneticist and biochemical geneticist at Emory, specializing in the diagnosis and treatment of inherited metabolic disorders, and a range of genetic disorders associated with dysmorphic features and intellectual disability. Dr.Li serves as the Medical Director of Emory Metabolic Clinic and Co-Chair of the Georgia Newborn Screening (NBS) Advisory Committee, she plays a key role in the development, implementation, and clinical follow-up of NBS for patients with Inborn Errors of Metabolism.
Dr. Li is actively engaged in collaborative gene discovery efforts and advancing the understanding and care for rare genetic diseases. She currently serves as the Medical Director of the Emory CTCF-Related Disorder (CRD) Center and is the site Principal Investigator for the Differences of Sex Development Translational Research Network (DSD-TRN).
In her commitment to education, Dr. Li holds the position of Program Director for the Medical Biochemical Genetics Fellowship Program at Emory and serves as the Faculty Advisor for the Emory Student Genetics Interest Group. Additionally, she leads multiple phase I/II and III clinical trials, focused on developing innovative treatments for genetic and metabolic disorders, further contributing to advancements in the rare disease field.
Dr. Li is actively engaged in collaborative gene discovery efforts and advancing the understanding and care for rare genetic diseases. She currently serves as the Medical Director of the Emory CTCF-Related Disorder (CRD) Center and is the site Principal Investigator for the Differences of Sex Development Translational Research Network (DSD-TRN).
In her commitment to education, Dr. Li holds the position of Program Director for the Medical Biochemical Genetics Fellowship Program at Emory and serves as the Faculty Advisor for the Emory Student Genetics Interest Group. Additionally, she leads multiple phase I/II and III clinical trials, focused on developing innovative treatments for genetic and metabolic disorders, further contributing to advancements in the rare disease field.
Sessions
-
22-Mar-2025Los Angeles Convention CentreMultidisciplinary Patient-Centered Care for Differences of Sex Development (DSD)